← All trials
NCT03109834
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 25, 2004
- Primary completion
- Mar 28, 2007
- Completion date
- Mar 28, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 105
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Bonn Education Association for Dietetics r.A., Cologne, GermanyLead sponsor
- Bonn Education Association for Dietetics r.A., Cologne, GermanyOverall official - principal investigator
- Bonn Education Association for Dietetics r.A., Cologne, GermanyReponsible party - principal investigator
- FomMed HealthCare AGCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.